RECRUITING

Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Stigma due to health conditions increases disease burden and adversely impacts health. The internalization of health-related stigma is associated with impaired mental health and quality of life. The current project will test the effects of a novel, transdiagnostic, group counseling intervention, and peer support, to determine the optimal method for helping patients cope with health-related stigma, reducing its internalization, and enhancing patient quality of life.

Official Title

Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma

Quick Facts

Study Start:2024-10-03
Study Completion:2027-03-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05561595

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 18 years or older
  2. * At least one of the following stigmatized health conditions:
  3. * Obesity (or high body weight that negatively affects health)
  4. * Skin disease (including but not limited to psoriasis, eczema, or vitiligo)
  5. * Cancer (including but not limited to lung, breast, cervical, colorectal, gynecologic, prostate, or head and neck; including individuals in remission)
  6. * HIV
  7. * Type 1 or type 2 diabetes
  8. * Chronic pain
  9. * Reported internalization of health-related stigma, as determined by a pre-specified cutoff score on internalized stigma measure and confirmed by interview
  1. * Current or recent (past 3 months) receipt of psychotherapy or a psychosocial or peer support intervention, or psychiatric hospitalization in the past 6 months
  2. * Recent (past 3 months) change in medications taken for psychiatric reasons
  3. * Current, active suicidal thoughts or suicide attempt within the past year
  4. * Current or past thought disorder or psychosis, or unmanaged bipolar disorder
  5. * Current alcohol/substance use disorder that requires immediate treatment
  6. * Health-related stigma due primarily to mental illness or substance use, or due to health conditions not specified in inclusion criteria.
  7. * No reported internalization of health-related stigma and/or score below pre-specified cutoff on internalized stigma measure
  8. * Unwilling or unable to complete study procedures

Contacts and Locations

Study Contact

Rebecca Pearl, PhD
CONTACT
352-294-5405
rebecca.pearl@phhp.ufl.edu

Principal Investigator

Rebecca Pearl, PhD
PRINCIPAL_INVESTIGATOR
University of Florida

Study Locations (Sites)

University of Florida
Gainesville, Florida, 32610
United States

Collaborators and Investigators

Sponsor: University of Florida

  • Rebecca Pearl, PhD, PRINCIPAL_INVESTIGATOR, University of Florida

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-03
Study Completion Date2027-03-31

Study Record Updates

Study Start Date2024-10-03
Study Completion Date2027-03-31

Terms related to this study

Additional Relevant MeSH Terms

  • Obesity
  • Skin Disease
  • Cancer
  • HIV
  • Diabetes
  • Chronic Pain